Clostridium butyricum MIYAIRI 588 contributes to the maintenance of intestinal microbiota diversity early after haematopoietic cell transplantation - Summary - MDSpire

Clostridium butyricum MIYAIRI 588 contributes to the maintenance of intestinal microbiota diversity early after haematopoietic cell transplantation

  • By

  • Kentaro Fukushima

  • Hayami Kudo

  • Kentaro Oka

  • Atsushi Hayashi

  • Makoto Onizuka

  • Shinsuke Kusakabe

  • Akihisa Hino

  • Motomichi Takahashi

  • Kiyoshi Takeda

  • Masaki Mori

  • Kiyoshi Ando

  • Naoki Hosen

  • March 2, 2024

  • 0 min

Share

Objective:

To evaluate the effects of administering CBM588 prophylactically on the intestinal microbiota after HSCT.

Key Findings:
  • CBM588 administration was associated with increased diversity of intestinal microbiota post-HSCT.
  • Specific beneficial bacteria, such as Bifidobacterium and Lactobacillus, increased in abundance.
  • The stability of the intestinal microbiota positively influenced patient prognosis during the peri-transplant period.
Interpretation:

Prophylactic administration of CBM588 may enhance intestinal microbiota diversity and stability, potentially improving outcomes for HSCT patients.

Limitations:
  • The study was limited to a specific ethnic group (Japanese patients), which may affect the applicability of the findings to other populations.
  • The relatively small sample size may limit the generalizability of the results.
Conclusion:

CBM588 shows promise as a live biotherapeutic product to support intestinal microbiota diversity in patients undergoing HSCT, highlighting the need for further investigation.

Original Source(s)

Related Content